The American Medical Association wants the U.S. government to review marijuana's status as an illegal drug, a move that's considered important by supporters of medical marijuana.
"This shift, coming from what has historically been America's most cautious and conservative major medical organization, is historic," Aaron Houston, director of government relations for the Marijuana Policy Project (MPP), which seeks to reform U.S. marijuana laws, said in a news release. "Marijuana's Schedule I status is not just scientifically untenable, given the wealth of recent data showing it to be both safe and effective for chronic pain and other conditions, but it's been a major obstacle to needed research."
Currently, marijuana is classified as a Schedule I drug that has no accepted medical use and is unsafe for use even under medical supervision. Heroin, LSD and PCP are among the other Schedule I drugs, MPP said.
On Tuesday, the AMA's House of Delegates adopted a new policy position urging "that marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods."
But the policy authors added that this new position shouldn't be regarded as an endorsement of state medical marijuana programs.